Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCL2, also known as monocyte chemoattractant protein-1 (MCP-1), is a proinflammatory chemokine that mediates the recruitment of monocytes and other immune cells to sites of inflammation. It plays a significant role in tumor progression, atherosclerosis, and other chronic inflammatory conditions, making it a relevant therapeutic target.
Inhibition of CCL2 binding to CCR2, preventing downstream signaling and cell migration
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CC Chemokine Ligand 2 (CCL2).